Literature DB >> 17309100

Screening the human serum proteome for genotype-phenotype associations: an analysis of the IL6 -174G>C polymorphism.

Christine M Hegedus1, Christine F Skibola1, Paige Bracci2, Elizabeth A Holly2, Martyn T Smith1.   

Abstract

Interleukin (IL)-6 is a circulatory, pleiotropic cytokine with multiple roles in the immune system. Both IL-6 and the IL6 -174G>C promoter polymorphism have been linked to various diseases associated with inflammation. However, the mechanism by which the polymorphism influences disease risk is unclear. We postulated that serum proteome analysis of individuals with different IL6 -174G>C genotypes would provide insight on genotype-phenotype associations of this polymorphism and its role in disease susceptibility. Serum from a random sample of control participants in an ongoing population-based case-control study of non-Hodgkin lymphoma was pooled by IL6 genotype and used to screen for the optimal SELDI-TOF MS arrays for analysis. We report differences in serum protein expression of individuals with specific genotypes based on pooled and individual sample analysis. In particular, we report an association of the -174C allele with increased apolipoprotein C-I (ApoC-I). Additionally, we corroborate previous findings of an association of the -174C allele with lower autoantibodies to heat shock protein 60 and confirm the absence of any association between the IL6 -174G>C genotype and serum IL-6 levels. This study illustrates that proteome analysis can enhance our understanding of genotype-phenotype relationships. Additional studies are needed to clarify the interaction between the IL6 -174G>C polymorphism and ApoC-I.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309100     DOI: 10.1002/pmic.200600366

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  7 in total

1.  IL-6 -174 c/c genotype is not conclusively a low IL-6 production phenotype.

Authors:  Johanna Nokso-Koivisto; Janak A Patel; Tasnee Chonmaitree
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

2.  Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study.

Authors:  Myriam Fornage; Y Aron Chiang; Ellen S O'Meara; Bruce M Psaty; Alexander P Reiner; David S Siscovick; Russell P Tracy; W T Longstreth
Journal:  Stroke       Date:  2008-04-24       Impact factor: 7.914

Review 3.  Genetic susceptibility to lymphoma.

Authors:  Christine F Skibola; John D Curry; Alexandra Nieters
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

4.  Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study.

Authors:  Marieke Emonts; Mieke J M W Hazes; Jeanine J Houwing-Duistermaat; Christa E van der Gaast-de Jongh; Lisette de Vogel; Huub K H Han; Jacques M G W Wouters; Jon D Laman; Radboud J E M Dolhain
Journal:  BMC Med Genet       Date:  2011-03-07       Impact factor: 2.103

5.  An integrated expression phenotype mapping approach defines common variants in LEP, ALOX15 and CAPNS1 associated with induction of IL-6.

Authors:  Benjamin P Fairfax; Fredrik O Vannberg; Jayachandran Radhakrishnan; Hakon Hakonarson; Brendan J Keating; Adrian V S Hill; Julian C Knight
Journal:  Hum Mol Genet       Date:  2009-11-26       Impact factor: 6.150

6.  The interleukin 6 -174 C/C genotype predicts greater rhinovirus illness.

Authors:  William J Doyle; Margaretha L Casselbrant; Ha-Sheng Li-Korotky; Allison P Cullen Doyle; Chia-Yee Lo; Ronald Turner; Sheldon Cohen
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

Review 7.  Applications of SELDI-MS technology in oncology.

Authors:  L C Whelan; K A R Power; D T McDowell; J Kennedy; W M Gallagher
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.